Shiga, Japan

Keiko Kubo


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiko Kubo: Innovator in Nucleic Acid Modification

Introduction

Keiko Kubo is a prominent inventor based in Shiga, Japan. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid modification. With a total of 2 patents, her work has the potential to impact various applications in genetic research and diagnostics.

Latest Patents

Keiko Kubo's latest patents focus on innovative methods for modifying nucleic acids. One of her inventions pertains to a method for modifying a nucleic acid contained in a sample. This method involves bringing the sample into contact with a nucleic acid-modifying agent in the presence of an acidic polysaccharide and/or a nucleotide. Additionally, she has developed a method for selectively detecting a nucleic acid derived from living cells in the sample. This process includes modifying the nucleic acid and then detecting an unmodified nucleic acid from the sample. Her inventions also encompass a kit and composition for use in these methods.

Career Highlights

Keiko Kubo is associated with Takara Bio Inc., a company known for its advancements in biotechnology and molecular biology. Her work at the company has allowed her to focus on innovative solutions that enhance the understanding and manipulation of genetic materials.

Collaborations

Keiko collaborates with notable colleagues, including Junko Yamamoto and Takashi Uemori. These partnerships contribute to the advancement of research and development in their respective fields.

Conclusion

Keiko Kubo's contributions to nucleic acid modification represent a significant advancement in molecular biology. Her innovative methods and collaborative efforts continue to pave the way for future research and applications in genetic science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…